Page last updated: 2024-10-29

isoproterenol and Cardiac Cancer

isoproterenol has been researched along with Cardiac Cancer in 2 studies

Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drvota, V1
Wei, H1
Häggblad, J1
Carlsson, B1
Sylvén, C1
Poupa, O1
Carlsten, A1

Other Studies

2 other studies available for isoproterenol and Cardiac Cancer

ArticleYear
Beta-adrenergic receptor function in cultured AT-1 cardiomyocytes.
    Biochemical and biophysical research communications, 1995, Feb-06, Volume: 207, Issue:1

    Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Calcium; Cell Line; Cyclic AMP; Cytosol; Heart; He

1995
Isoproterenol-induced cardiac lesions in frog observed in vivo.
    Canadian journal of physiology and pharmacology, 1970, Volume: 48, Issue:5

    Topics: Animals; Anura; Blood Pressure; Disease Models, Animal; Female; Heart; Heart Aneurysm; Heart Disease

1970